Skip to main content

Ocimum Biosolutions Signs Marketing and Distribution Agreement with Science-Partners

NEW YORK, Aug. 31 (GenomeWeb News) - Ocimum Biosolutions said today that it has signed a marketing agreement with UK-based Science-Partners related to the marketing and distribution of Laboratory Information Management Systems.


Under the terms of the agreement, Science-Partners, based in Oxford, will market and distribute Indianapolis-based Ocimum's LIMS, including Biotracker, Pharmatracker, and Toxcheck, in the UKand North European markets. Science-Partners will also market Ocimum's bioinformatics and gene optimization tools, including Genchek, Genowiz, RNAchek, Optgene, and Nutrabase in the UKand Europe.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.